Skip to main content
Zenotech Laboratories Limited logo

Zenotech Laboratories Limited — Investor Relations & Filings

Ticker · 532039 ISIN · INE486F01012 BSE.NS Manufacturing
Filings indexed 1 across all filing types
Latest filing 2026-05-27 Regulatory Filings
Country IN India
Listing BSE.NS 532039

About Zenotech Laboratories Limited

https://zenotechlab.com/

Zenotech Laboratories Limited is a specialty generic company focused on the development and manufacture of high-value biopharmaceutical and injectable products. The organization specializes in oncology and biotechnology, producing a range of therapeutic solutions including Granulocyte-colony stimulating factor (G-CSF) and various cytotoxic formulations. Its core operations involve advanced research and development aimed at creating complex biologics and small molecule injectables that meet international quality standards. By utilizing sophisticated manufacturing technologies, the company provides cost-effective treatments for chronic conditions. Zenotech serves global healthcare markets through a robust pipeline of specialty products and strategic collaborations, emphasizing technical excellence in the production of life-saving medications.

Recent filings

Filing Released Lang Actions
Submission of Annual Secretarial Compliance Report for the financial year 2025-26
Regulatory Filings Classification · 85% confidence The document is an Annual Secretarial Compliance Report under Regulation 24A of SEBI LODR 2015 issued by the Practicing Company Secretary and filed with the stock exchange. It is not a full financial or management report, but a statutory compliance certificate. It does not fit into categories like Annual Report (10-K), Audit Report (AR) (financial audit), or any direct financial statement filing. Therefore it falls into the catch-all Regulatory Filings category.
2026-05-27 English

Browse filings by year

1 year

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.